Devyser News and Activities

Devyser is a company listed under the stock ticker DVYSR (SE).

View the org chart displaying its 22 main executives

Most searched biographies at Devyser

• Jan Wahlström, Chief Executive Officer
• Mia Arnhult, Chairman of the Board
• Fredrik Dahl, Director

Popular executive movements at Devyser

• Niklas Axelsson will join the company as Chief Financial Officer on Nov. 21, 2026  (posted on May 25 2026).
• Theis Kipling, Chief Commercial Officer, has left the company  (posted on April 8 2026).

Create your alert
to follow the executive moves at Devyser.

Devyser has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Devyser

• Press releases
• Devyser - Blog
• Devyser - Blog
• News and Press I Devyser

Social media about Devyser

• Devyser on Wikipedia, Google News & Yahoo Finance
• Devyser on LinkedIn, X (Twitter) & YouTube